​

Funding Round

Series A - Tetra Therapeutics

Series A - Tetra Therapeutics

Investment Firm

Overview

Tetra Therapeutics is a clinical stage biotechnology company developing a portfolio of therapeutic products.

Announced Date

Nov 29, 2016

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Apjohn ventures

Apjohn ventures

Apjohn ventures is a debt and late_stage_venture firm.

Participant Investors

4

Investor Name
Participant InvestorAlzheimer's Drug Discovery Foundation
Participant InvestorGrand Angels
Participant InvestorApjohn ventures
Participant InvestorDolby Family Ventures

Round Details and Background

Tetra Therapeutics raised $5000000 on 2016-11-29 in Series A

Tetra Therapeutics is a clinical stage biotechnology company developing a portfolio of therapeutic products.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 29, 2016
Series A - Tetra Therapeutics
4-5.0M

Recent Activity

There is no recent news or activity for this profile.